about
Molecular imaging of EGFR/HER2 cancer biomarkers by protein MRI contrast agentsPreclinical multimodality phantom design for quality assurance of tumor size measurementUse of DNA microarray and small animal positron emission tomography in preclinical drug evaluation of RAF265, a novel B-Raf/VEGFR-2 inhibitor.Translational molecular imaging for cancer.Anticancer activity of an imageable curcuminoid 1-[2-aminoethyl-(6-hydrazinopyridine-3-carbamidyl)-3,5-bis-(2-fluorobenzylidene)-4-piperidone (EFAH)Bioengineering approaches to study multidrug resistance in tumor cells.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Can small animal imaging accelerate drug development?
@ast
Can small animal imaging accelerate drug development?
@en
type
label
Can small animal imaging accelerate drug development?
@ast
Can small animal imaging accelerate drug development?
@en
prefLabel
Can small animal imaging accelerate drug development?
@ast
Can small animal imaging accelerate drug development?
@en
P356
P1476
Can small animal imaging accelerate drug development?
@en
P2093
Martin G Pomper
P304
P356
10.1002/JCB.10443
P577
2002-01-01T00:00:00Z